000 01221 a2200385 4500
005 20250513101904.0
264 0 _c19961021
008 199610s 0 0 eng d
022 _a0770-3198
024 7 _a10.1007/BF02215855
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMalaise, M G
245 0 0 _aThe use of Sandimmun (cyclosporin A) in severe refractory rheumatoid arthritis: the Belgian experience.
_h[electronic resource]
260 _bClinical rheumatology
_cSep 1995
300 _a26-32 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aArthritis, Rheumatoid
_xblood
650 0 4 _aCreatinine
_xblood
650 0 4 _aCyclosporine
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSeverity of Illness Index
650 0 4 _aTime Factors
700 1 _aDe Keyser, P
700 1 _aDe Backer, M
700 1 _avan Lierde, M A
700 1 _aLesaffre, E
773 0 _tClinical rheumatology
_gvol. 14 Suppl 2
_gp. 26-32
856 4 0 _uhttps://doi.org/10.1007/BF02215855
_zAvailable from publisher's website
999 _c8840824
_d8840824